Impaired cognitive performance in asymptomatic peripheral arterial disease: Relation to C-reactive protein and D-dimer levels

Age and Ageing

Volumn 35, Issue 1, 2006, Pages 60-65

  Mangiafico, Roberto Antonio ^a   Sarnataro, Fabrizio ^a   Mangiafico, Marco ^a   Fiore, Carmelo Erio ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

C reactive protein; Cognitive impairment; D dimer; Elderly; Fibrinogen; Peripheral arterial disease

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; D DIMER; FIBRINOGEN;

ACADEMIC ACHIEVEMENT; AGE; AGED; ARTERY DISEASE; ARTICLE; ATTENTION; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; FEMALE; GENDER; HUMAN; HYPERCOAGULABILITY; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; PSYCHOMETRY; RISK ASSESSMENT; SCORING SYSTEM; VERBAL MEMORY; WORKING MEMORY;

AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COGNITION; COGNITION DISORDERS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FOLLOW-UP STUDIES; HUMANS; MALE; NEPHELOMETRY AND TURBIDIMETRY; NEUROPSYCHOLOGICAL TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 31144443627     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afi219     Document Type: Article

References (30)

1. Leng GC, Fowkes FG, Lee AJ, Dunbar J, Housley E, Ruckley CV. Use of ankle brachial pressure index to predict cardiovascular events and death: A cohort study. BMJ 1996; 313: 1440-4.
2. Stoffers HE, Rinkens PE, Kester AD, Kaiser V, Knottnerus JA. The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease. Int J Epidemiol 1996; 25: 282-90.
3. Phillips NA, Mate-Kole CC. Cognitive deficits in peripheral vascular disease. A comparison of mild stroke patients and normal control subjects. Stroke 1997; 28: 777-84.
4. Waldstein SR, Tankard CF, Maier KJ et al. Peripheral arterial disease and cognitive function. Psychosom Med 2003; 65: 757-63.
5. Rao R, Jackson S, Howard R. Neuropsychological impairment in stroke, carotid stenosis, and peripheral vascular disease. A comparison with healthy community residents. Stroke 1999; 30: 2167-73.
6. Elwood PC, Pickering J, Bayer A, Gallacher JE. Vascular disease and cognitive function in older men in the Caerphilly cohort. Age Ageing 2002; 31: 43-8.
7. Singh-Manoux A, Britton AR, Marmot M. Vascular disease and cognitive function: Evidence from the Whitehall II Study. J Am Geriatr Soc 2003; 51: 1445-50.
8. Heinrich J, Schulte H, Schonfeld R, Kohler E, Assmann G. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thromb Haemost 1995; 73: 374-9.
9. Yaffe K, Lindquist K, Penninx BW et al. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 2003; 61: 76-80.
10. Wilson CJ, Cohen HJ, Pieper CF. Cross-linked fibrin degradation products (D-dimer), plasma cytokines, and cognitive decline in community-dwelling elderly persons. J Am Geriatr Soc 2003; 51: 1374-81.
11. Cerhan JR, Folsom AR, Mortimer JA et al. Correlates of cognitive function in middle-aged adults. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Gerontology 1998; 44: 95-105.
12. Fowkes FG. The measurement of atherosclerotic peripheral arterial disease in epidemiological surveys. Int J Epidemiol 1988; 17: 248-54.
13. Wechsler D. Wechsler Adult Intelligence Scale, Revised. New York, NY: Psychological Corporation, 1981.
14. Reitan RM, Davison LA. Clinical neuropsychology: Current status and applications. New York, NY: Wiley, 1974.
15. Rey A. L'examen psychologique dans les cas d'encéphalopathie traumatique. Arch Psychol 1941; 28: 286-340.
16. Osterrieth PA. Le test de copie d'une figure complexe. Arch Psychol 1944; 30: 206-356.
17. Bots ML, van Swieten JC, Breteler MM et al. Cerebral white matter lesions and atherosclerosis in the Rotterdam Study. Lancet 1993; 341: 1232-37.
18. Jorgensen HS, Nakayama H, Raaschou HO, Gam J, Olsen TS. Silent infarction in acute stroke patients. Prevalence, localization, risk factors, and clinical significance: The Copenhagen Stroke Study. Stroke 1994; 25: 97-104.
19. Swan GE, DeCarli C, Miller BL, Reed T, Wolf PA, Carmelli D. Biobehavioral characteristics of nondemented older adults with subclinical brain atrophy. Neurology 2000; 54: 2108-14.
20. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003; 348: 1215-22.
21. de Groot JC, de Leeuw FE, Oudkerk M et al. Cerebral white matter lesions and cognitive function: The Rotterdam Scan Study. Ann Neurol 2000; 47: 145-51.
22. Breteler MM. Vascular risk factors for Alzheimer's disease: An epidemiologic perspective. Neurobiol Aging 2000; 21: 153-60.
23. Lindsberg PJ, Grau AJ. Inflammation and infections as risk factors for ischemic stroke. Stroke 2003; 34: 2518-32.
24. Volanakis JE. Complement activation by C-reactive protein complexes. Ann N Y Acad Sci 1982; 389: 235-50.
25. Galve-de Rochemonteix B, Wiktorowicz K, Kushner I, Dayer JM. C-reactive protein increases production of IL-1 alpha, IL-1 beta, and TNF-alpha, and expression of mRNA by human alveolar macrophages. J Leukoc Biol 1993; 53: 439-45.
26. Cermak J, Key NS, Bach RR, Balla J, Jacob HS, Vercellotti GM. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993; 82: 513-20.
27. Kario K, Matsuo T, Hoshide S, Umeda Y, Shimada K. Effect of thrombin inhibition in vascular dementia and silent cerebrovascular disease. An MR spectroscopy study. Stroke 1999; 30: 1033-7.
28. Robson SC, Shephard EG, Kirsch RE. Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-1 beta, IL-6 and plasminogen activator inhibitors from monocytes in vitro. Br J Haematol 1994; 86: 322-6.
29. Phillips NA. Thinking on your feet: A neuropsychological review of peripheral arterial disease. In Waldstein SR, Elias MF, eds. Neuropsychology of Cardiovascular Disease. Mahwah, NJ: Lawrence Erlbaum Associates, 2001 pp. 121-42.
30. Ingles JL, Wentzel C, Fisk JD, Rockwood K. Neuropsychological predictors of incident dementia in patients with vascular cognitive impairment, without dementia. Stroke 2002; 33: 1999-2002.